ERBB2 and breast cancer: While no association was found between an alteration in the PIKCA gene (encoding the catalytic subunit of PI3K, p110) and resistance to CDK4/6is, mutations in AKT1, AURKA, and KRAS genes were found in CDK4/6i-resistant HR+/HER2-negative BC.